000 01416 a2200385 4500
005 20250516110242.0
264 0 _c20130617
008 201306s 0 0 eng d
022 _a1476-5381
024 7 _a10.1111/j.1476-5381.2012.02183.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aJain, U
245 0 0 _aThe C5a receptor antagonist PMX205 ameliorates experimentally induced colitis associated with increased IL-4 and IL-10.
_h[electronic resource]
260 _bBritish journal of pharmacology
_cJan 2013
300 _a488-501 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAnti-Inflammatory Agents
_xpharmacology
650 0 4 _aColitis
_xchemically induced
650 0 4 _aComplement C3a
_ximmunology
650 0 4 _aComplement C5a
_ximmunology
650 0 4 _aCytokines
_ximmunology
650 0 4 _aDextran Sulfate
650 0 4 _aMale
650 0 4 _aMice
650 0 4 _aMice, Inbred BALB C
650 0 4 _aMice, Inbred C57BL
650 0 4 _aMice, Knockout
650 0 4 _aPeptides, Cyclic
_xpharmacology
650 0 4 _aReceptor, Anaphylatoxin C5a
_xantagonists & inhibitors
700 1 _aWoodruff, T M
700 1 _aStadnyk, A W
773 0 _tBritish journal of pharmacology
_gvol. 168
_gno. 2
_gp. 488-501
856 4 0 _uhttps://doi.org/10.1111/j.1476-5381.2012.02183.x
_zAvailable from publisher's website
999 _c22054858
_d22054858